Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


PharmAthene to Webcast its Third Quarter Conference Call on November 13, 2007 at 4:30 P.M. Eastern Time

    ANNAPOLIS, Md., Nov. 6 /PRNewswire-FirstCall/ -- PharmAthene (Amex:
PIP), a biodefense company specializing in the development of medical
countermeasures against biological and chemical threats, will webcast its
third quarter 2007 financial results conference call on Tuesday, November
13, 2007 at 4:30 p.m. Eastern Time. David Wright, President and Chief
Executive Officer and Christopher Camut, Vice President and Chief Financial
Officer will review the Company's operations, business outlook and current
financial results. A press release announcing the third quarter results
will be issued at 4:00 p.m. E.T. on Tuesday, November 13, 2007, and be
available on the Company's website.
    Conference Call Information
    To access the call, the dial-in number within the United States is
866-510-0676. The dial-in number for international callers is 617-597-5361.
The participant passcode is 15368854.
    Conference Call Replay
    A replay of the conference call will be available for 30 days,
beginning at approximately 6:30 p.m. E.T. November 13th, 2007 until
approximately 11:59 p.m. E.T. on December 13, 2007. The dial-in number from
within the United States is 888-286-8010. For international callers, the
dial-in number is 617-801-6888. The participant passcode is 84931672.
    Webcast
    The conference call will be also be webcast live and is accessible from
the company's website at http://www.pharmathene.com. A link to the webcast may be
accessed on the home page or under the 'Investor Relations' section of the
website. The replay of the call will be available via webcast for 30 days,
or until December 13, 2007.
    About PharmAthene, Inc.
    PharmAthene is a biodefense company formed in 2001 to meet the critical
needs of the United States by developing biodefense products. PharmAthene
is dedicated to the rapid development of important and novel
biotherapeutics to address biological pathogens and chemicals that may be
used as weapons of bioterror. PharmAthene's lead programs include
Valortim(TM) and Protexia(R). For more information on PharmAthene, please
visit http://www.pharmathene.com.


SOURCE PharmAthene




Back to Topback to top

Related links:
  • http://www.pharmathene.com
    CONTACT:
    Stacey Jurchison of PharmAthene, Inc.,
    +1-410-269-2610, JurchisonS@PharmAthene.com